Open Access

Targeting cardiovascular risk factors with GLP-1 RAs in people with obesity

Event: ESC Congress 2022
Topic: Obesity and Diabetes
Session type: Satellite Symposium
Sponsored by Novo Nordisk
Date: 27 August 2022
Time: 10:15 - 11:00

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Welcome and introduction.

Speaker: Professor A. Lincoff (Cleveland, US)
Thumbnail

CV risk: what's weight got to do with it?

Speaker: Professor J. Deanfield (London, GB)
Thumbnail

Improvements in CV risk factors: STEP by STEP.

Speaker: Doctor B. Scirica (Boston, US)
Thumbnail

SELECT and STEP-HFpEF: new horizons.

Speaker: Professor A. Lincoff (Cleveland, US)
Thumbnail

Panel discussion.

Speaker: Professor A. Lincoff (Cleveland, US)
Speaker: Professor J. Deanfield (London, GB)
Speaker: Doctor B. Scirica (Boston, US)
Thumbnail

7 speakers from this session

Professor A Michael Lincoff

Cleveland Clinic Foundation, Cleveland (United States of America)
6 presentations
0 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
40 presentations
2 followers

Doctor Benjamin Morgan Scirica

Brigham and Women's Hospital, Boston (United States of America)
8 presentations
0 follower

Professor A Michael Lincoff

Cleveland Clinic Foundation, Cleveland (United States of America)
6 presentations
0 follower

Professor A Michael Lincoff

Cleveland Clinic Foundation, Cleveland (United States of America)
6 presentations
0 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
40 presentations
2 followers

Doctor Benjamin Morgan Scirica

Brigham and Women's Hospital, Boston (United States of America)
8 presentations
0 follower

This platform is supported by

logo Novo Nordisk